Hosted on MSN1mon
Henry Schein targets $4.80-$4.94 EPS for 2025, supported by restructuring and strategic growthThis partnership aligns with the strategic plan and is anticipated to support ... potential impact due to supply chain adjustments. Henry Schein demonstrated solid progress in Q4 2024, driven ...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq ... We continued to make progress on our 2022 to 2024 BOLD+1 Strategic Plan which we recently completed, exceeding our 2024 target ...
Learn more about whether BrightSpring Health Services, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ ...
Henry Schein undertakes no obligation to revise or ... We continue to make progress as we sunset our 2022 to 2024 BOLD+1 Strategic Plan which is now completed. We exceeded our key goal of ...
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Henry Schein (NASDAQ:HSIC) in the last three months. The table below summarizes their recent ...
Henry Schein Inc (NASDAQ:HSIC) has successfully completed its 2022 to 2024 BOLD+1 Strategic Plan, with a focus on high-growth, high-margin businesses. The company has simplified its organizational ...
Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.
Feb 25 (Reuters) - Henry Schein (HSIC.O), opens new tab forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid ...
Media roundtable sessions: “Conversations with Henry Schein: Exploring the Present and Future of Oral Health” will take place to discuss digitalization in dentistry; Henry Schein will also ...
Celsius and Alnylam rally but VNET falls. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results